Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review
Introduction As oral factor Xa (oFXa) inhibitor use has increased, so has publication of case series describing related bleeding managed with four-factor prothrombin complex concentrate (4F-PCC).Objective This review aimed to identify case series describing 4F-PCC management of oFXa inhibitor-relate...
Saved in:
| Main Authors: | Craig I Coleman, Olivia S Costa, William L Baker, Yuani Roman-Morillo, Kelly McNeil-Posey, Belinda Lovelace, C Michael White |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-11-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/11/e040499.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of factor Xa inhibitor–related traumatic non‐intracranial bleeding events with andexanet alfa or four‐factor prothrombin complex concentrate in a US multicenter observational study
by: Paul P. Dobesh, et al.
Published: (2024-12-01) -
Clinical and health care resource use burden of hospitalizations for oral factor Xa inhibitor‐associated major bleeding: A real‐world analysis of Medicare beneficiaries
by: James M. Williams, et al.
Published: (2023-06-01) -
91 Making It Count: Evaluating an Intervention to Increase Usability of Factor Xa Inhibitor Anti-Xa Levels
by: Emily Tisler, et al.
Published: (2025-05-01) -
Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Randomized Controlled Trials
by: Majed A. Refaai, et al.
Published: (2017-01-01) -
POSSIBILITIES OF INHIBITING ANTICOAGULANT ACTIVITIES THAT INHIBIT XA-FACTOR
by: A. D. Erlich
Published: (2019-06-01)